These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 10576374

  • 1. Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients.
    Markovic S, Drozina G, Vovk M, Fidler-Jenko M.
    Hepatogastroenterology; 1999; 46(29):2925-30. PubMed ID: 10576374
    [Abstract] [Full Text] [Related]

  • 2. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
    Ji D, Cao J, Hong X, Li J, Wang J, Chen F, Wang C, Zou S.
    Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883
    [Abstract] [Full Text] [Related]

  • 3. Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma.
    Matsue K, Kimura S, Takanashi Y, Iwama K, Fujiwara H, Yamakura M, Takeuchi M.
    Cancer; 2010 Oct 15; 116(20):4769-76. PubMed ID: 20597091
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations.
    Picardi M, Pane F, Quintarelli C, De Renzo A, Del Giudice A, De Divitiis B, Persico M, Ciancia R, Salvatore F, Rotoli B.
    Haematologica; 2003 Nov 15; 88(11):1296-303. PubMed ID: 14607759
    [Abstract] [Full Text] [Related]

  • 5. Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.
    Koo YX, Tay M, Teh YE, Teng D, Tan DS, Tan IB, Tai DW, Quek R, Tao M, Lim ST.
    Ann Hematol; 2011 Oct 15; 90(10):1219-23. PubMed ID: 21520001
    [Abstract] [Full Text] [Related]

  • 6. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
    Yeo W, Chan TC, Leung NW, Lam WY, Mo FK, Chu MT, Chan HL, Hui EP, Lei KI, Mok TS, Chan PK.
    J Clin Oncol; 2009 Feb 01; 27(4):605-11. PubMed ID: 19075267
    [Abstract] [Full Text] [Related]

  • 7. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
    Wu JM, Huang YH, Lee PC, Lin HC, Lee SD.
    J Clin Gastroenterol; 2009 Feb 01; 43(5):496-8. PubMed ID: 19247200
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention.
    Mindikoglu AL, Regev A, Schiff ER.
    Clin Gastroenterol Hepatol; 2006 Sep 01; 4(9):1076-81. PubMed ID: 16861051
    [Abstract] [Full Text] [Related]

  • 9. Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma.
    Cheng AL, Hsiung CA, Su IJ, Chen PJ, Chang MC, Tsao CJ, Kao WY, Uen WC, Hsu CH, Tien HF, Chao TY, Chen LT, Whang-Peng J, Lymphoma Committee of Taiwan Cooperative Oncology Group.
    Hepatology; 2003 Jun 01; 37(6):1320-8. PubMed ID: 12774010
    [Abstract] [Full Text] [Related]

  • 10. HBV and HCV infection in Japanese dental care workers.
    Nagao Y, Matsuoka H, Kawaguchi T, Ide T, Sata M.
    Int J Mol Med; 2008 Jun 01; 21(6):791-9. PubMed ID: 18506374
    [Abstract] [Full Text] [Related]

  • 11. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea.
    Park SC, Jeong SH, Kim J, Han CJ, Kim YC, Choi KS, Cho JH, Lee M, Jung HH, Ki SS, Chang YH, Lee SS, Park YH, Lee KH.
    J Med Virol; 2008 Jun 01; 80(6):960-6. PubMed ID: 18428141
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.
    Trop Gastroenterol; 2007 Jun 01; 28(1):19-23. PubMed ID: 17896605
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
    Huang H, Cai Q, Lin T, Lin X, Liu Y, Gao Y, Peng R.
    Expert Opin Pharmacother; 2009 Oct 01; 10(15):2399-406. PubMed ID: 19761353
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.
    Challine D, Buisson M, Cadilhac M, Germanidis G, Joab I, Eliaszewicz M, Caumes E, Flahault A, Fillet AM, Pawlotsky JM, Seigneurin JM.
    J Med Virol; 2002 Aug 01; 67(4):510-5. PubMed ID: 12115996
    [Abstract] [Full Text] [Related]

  • 16. Reactivation of hepatitis B virus in patients with undetectable HBsAg undergoing chemotherapy for malignant lymphoma or multiple myeloma.
    Matsui T, Kang JH, Nojima M, Tomonari A, Aoki H, Yamazaki H, Yane K, Tsuji K, Andoh S, Andoh S, Sakai H, Maemori M, Maguchi H, Tanaka Y.
    J Med Virol; 2013 Nov 01; 85(11):1900-6. PubMed ID: 23926082
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis.
    Esteve M, Saro C, González-Huix F, Suarez F, Forné M, Viver JM.
    Gut; 2004 Sep 01; 53(9):1363-5. PubMed ID: 15306601
    [Abstract] [Full Text] [Related]

  • 19. Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy--a prospective case series.
    Vassiliadis T, Garipidou V, Tziomalos K, Perifanis V, Giouleme O, Vakalopoulou S.
    Am J Hematol; 2005 Nov 01; 80(3):197-203. PubMed ID: 16247746
    [Abstract] [Full Text] [Related]

  • 20. Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma.
    Tsutsumi Y, Tanaka J, Kawamura T, Miura T, Kanamori H, Obara S, Asaka M, Imamura M, Masauzi N.
    Ann Hematol; 2004 Jan 01; 83(1):58-60. PubMed ID: 14513286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.